TrialClinical & experimental metastasis2019

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer.

Federico Carbone et al.PubMed ↗Publisher ↗

No numbers read from the abstract.